- Report
- June 2025
- 50 Pages
Global
From €2394EUR$2,650USD£2,047GBP
Cetraxate is a drug used to treat gastrointestinal disorders, such as irritable bowel syndrome, ulcerative colitis, and Crohn's disease. It is a prodrug of mesalazine, which is an anti-inflammatory drug used to reduce inflammation in the gastrointestinal tract. Cetraxate is available in both oral and rectal formulations, and is typically prescribed for long-term use. It is generally well-tolerated, with few side effects.
Cetraxate is one of many drugs used to treat gastrointestinal disorders, and is often used in combination with other medications. It is available in many countries, and is often prescribed by gastroenterologists.
Some companies that produce Cetraxate include Pfizer, Merck, and AstraZeneca. Show Less Read more